| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9185621 | Thrombosis Research | 2005 | 9 Pages |
Abstract
Acute thrombocytopenia after eptifibatide injection was caused by the transient redistribution of platelets to the liver. Attenuation of the decrease in platelet count and hepatic sequestration by abciximab and IVIG suggests that thrombocytopenia may have been caused by ligand-induced binding site antigen induction and recognition by the reticuloendothelial system.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Kenichi A. Tanaka, Nobuyuki Katori, Andrew B. Kelly, Harry Kotze, Ulla Marzec, Stephen R. Hanson,